References
- L. Pang et al., Preparation and anti-tumor application of hyaluronic acid-based material for disulfide and copper ions co-delivery, Sci. China Technol. Sci. 64 (9), 2023 (2021). DOI: https://doi.org/10.1007/s11431-021-1841-y.
- L. Pang et al., Design of crown ether based micelles and their anti-tumor properties by perturbing potassium ion homeostasis, Mater. Design 211, 110159 (2021). DOI: https://doi.org/10.1016/j.matdes.2021.110159.
- Y. Sun et al., Co-delivery of chemotherapeutic drugs and cell cycle regulatory agents using nanocarriers for cancer therapy, Sci. China Mater. 64 (8), 1827 (2021). DOI: https://doi.org/10.1007/s40843-020-1627-4.
- J. Lovell et al., Activatable photosensitizers for imaging and therapy[J], Chem. Rev. 110 (5), 2839 (2010). DOI: https://doi.org/10.1021/cr900236h.
- J. Celli et al., Imaging and photodynamic therapy: mechanisms, monitoring, and optimization[J], Chem. Rev. 110 (5), 2795 (2010). DOI: https://doi.org/10.1021/cr900300p.
- H. Cong et al., Tuning the brightness and photostability of organic dots for multivalent targeted cancer imaging and surgery, ACS Nano. 14 (5), 5887 (2020). DOI: https://doi.org/10.1021/acsnano.0c01034.
- H. Fan et al., A smart photosensitizer–manganese dioxide nanosystem for enhanced photodynamic therapy by reducing glutathione levels in cancer cells[J], Angew. Chem. Int. Ed. 55 (18), 5611 (2016). DOI: https://doi.org/10.1002/anie.201602071.
- K. Inoue, 5-Aminolevulinic acid-mediated photodynamic therapy for bladder cancer[J], Int. J. Urol. 24 (2), 97 (2017). DOI: https://doi.org/10.1111/iju.13291.
- W. Zhong et al., Recent advantage of hyaluronic acid for anti-cancer application: A review of “3S” transition approach, Carbohydr. Polym. 238, 116204 (2020). DOI: https://doi.org/10.1016/j.carbpol.2020.116204.
- M. J. Bader et al., Photodynamic therapy of bladder cancer: A phase I study using hexaminolevulinate (HAL)], Urol. Oncol. 31 (7), 1178 (2013). DOI: https://doi.org/10.1016/j.urolonc.2012.02.007.
- J. M. Brown, and W. R. Wilson, Exploiting tumour hypoxia in cancer treatment[J], Nat. Rev. Cancer 4 (6), 437 (2004). DOI: https://doi.org/10.1038/nrc1367.
- M. Hockel, and P. Vaupel, Tumor hypoxia: Definitions and current clinical, biologic, and molecular aspects[J], J. Natl. Cancer Inst. 93 (4), 266 (2001). DOI: https://doi.org/10.1093/jnci/93.4.266.
- X. Zhang et al., Enhanced fluorescence of gold nanoclusters composed of HAuCl4 and histidine by glutathione: glutathione detection and selective cancer cell imaging], Small 10 (24), 5170 (2014). DOI: https://doi.org/10.1002/smll.201401658.
- F. Jiang et al., Photodynamic therapy with photofrin in combination with buthionine sulfoximine (BSO) of human glioma in the nude rat[J], Lasers Med. Sci. 18 (3), 128 (2003). DOI: https://doi.org/10.1007/s10103-003-0269-3.
- T. Kiesslich et al., Differential effects of glucose deprivation on the cellular sensitivity towards photodynamic treatment-based production of reactive oxygen species and apoptosis-induction[J], FEBS Lett. 579 (1), 185 (2005). DOI: https://doi.org/10.1016/j.febslet.2004.11.073.
- C. Choi et al., Redox- and pH-responsive Fluorescent Carbon Nanoparticles-MnO2 -based FRET System for Tumor-targeted Drug Delivery, In Vivo, and, In Vitro[J], J. Ind. Eng. Chem. 63, 208 (2018). DOI: https://doi.org/10.1016/j.jiec.2018.02.017.
- C. Gordijo et al., Design of hybrid MnO2-polymer-lipid nanoparticles with tunable oxygen generation rates and tumor accumulation for cancer treatment[J], Adv. Funct. Mater. 25 (12), 1858 (2015). DOI: https://doi.org/10.1002/adfm.201404511.